£790.00

It has never been this cheap. We have no record of a lower price.

£790 today · cheaper than every other day in the last 3 months

2025-2030 World Outlook for Immuno Oncology Assays Report

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 16 days · 16 data points (no recent data)

Historical
Generating forecast…
£790.00 £750.50 £766.30 £782.10 £797.90 £813.70 £829.50 11 August 2026 14 August 2026 18 August 2026 22 August 2026 26 August 2026
View at Amazon ↗

Price data last checked 75 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 16 days • 1 price levels

Days at Price
16 days 0 4 8 12 16 £790 Days at Price

Price Analysis

Most common price: £790 (16 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 16 days

Description

Gain a comprehensive understanding of the global immuno oncology assays market with this detailed economic study. Covering more than 190 countries, this report provides essential data for professionals tracking industry shifts through 2030. By utilizing econometric models that project fundamental economic dynamics, the study provides estimates for latent demand, also known as potential industry earnings (P.I.E.), in millions of U.S. dollars. The report includes comparative benchmarks, such as each country's percent share of its specific region and its share of the global market. These metrics allow readers to quickly evaluate individual country performance against international standards. This resource serves as a vital tool for analyzing market potential and economic trends within the immuno oncology assay sector.

Key Features

Provides a detailed world outlook for immuno oncology assays spanning from 2025 to 2030.

Includes market data and analysis for more than 190 countries to support global strategy.

Offers latent demand estimates expressed as potential industry earnings (P.I.E.) in millions of U.S. dollars.

Delivers comparative benchmarks including percent share of both regional and global markets.

Uses econometric models to project fundamental economic dynamics across different countries.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
07 May 2024

Similar Products You Might Like

World Outlook for Immune-Oncology Treatments 2025-2030
99% match

World Outlook for Immune-Oncology Treatments 2025-2030

£790.00 25 Aug 2026
2023 Immuno-Oncology Report - Global Market Segmentation
98% match

2023 Immuno-Oncology Report - Global Market Segmentation

£795.00 25 Oct 2026
The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
98% match

The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

£795.00 13 Sep 2026
Chemotherapy and Antibody Therapy Outlook in India 2023-2028
98% match

Chemotherapy and Antibody Therapy Outlook in India 2023-2028

£515.00 07 Nov 2026
Chemotherapy and Antibody Therapy Outlook 2023-2028 Report
97% match

Chemotherapy and Antibody Therapy Outlook 2023-2028 Report

£520.00 02 Nov 2026
World Outlook for T-Cell Immunotherapies 2025-2030 Report
97% match

World Outlook for T-Cell Immunotherapies 2025-2030 Report

£790.00 28 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 01 Oct 2026
The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
97% match

The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

£885.00 02 Nov 2026
Cancer Diagnostics Lab Test Outlook in India 2023-2028
97% match

Cancer Diagnostics Lab Test Outlook in India 2023-2028

£515.00 02 Nov 2026
The 2021-2026 World Outlook for Cancer Biomarkers
97% match

The 2021-2026 World Outlook for Cancer Biomarkers

£795.00 06 Nov 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Cancer Vaccines in India
97% match

The 2023-2028 Outlook for Cancer Vaccines in India

£515.00 01 Oct 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 01 Oct 2026
The 2021-2026 World Outlook for Hematology and Oncology Products
97% match

The 2021-2026 World Outlook for Hematology and Oncology Products

£795.00 05 Nov 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028
97% match

Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028

£515.00 07 Nov 2026
US Cancer Supportive Care Outlook 2023-2028 Study Report
97% match

US Cancer Supportive Care Outlook 2023-2028 Study Report

£520.00 07 Nov 2026
India Cancer Supportive Care Drugs Outlook 2023-2028
97% match

India Cancer Supportive Care Drugs Outlook 2023-2028

£515.00 06 Nov 2026
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics
97% match

The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics

£790.00 29 Oct 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
97% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£520.00 06 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
2023-2028 US Cancer Screening Outlook - Market Study
97% match

2023-2028 US Cancer Screening Outlook - Market Study

£520.00 05 Nov 2026
Cancer Supportive Care Drugs Outlook 2023-2028 Report
97% match

Cancer Supportive Care Drugs Outlook 2023-2028 Report

£520.00 06 Nov 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study
97% match

Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study

£520.00 07 Nov 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 02 Nov 2026